Odonate Therapeutics Inc
Change company Symbol lookup
Select an option...
ODT Odonate Therapeutics Inc
SMBK SmartFinancial Inc
FHN First Horizon Corp (Tennessee)
STAF Staffing 360 Solutions Inc
TEL TE Connectivity Ltd
BOKF BOK Financial Corp
PRAA PRA Group Inc
XEL Xcel Energy Inc
XEC Cimarex Energy Co
XCUR Exicure Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

Price
Delayed
$3.45
Day's Change
0.13 (3.92%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.59
Day's Low
3.26
Volume
(Heavy Day)

Today's volume of 963,820 shares is on pace to be much greater than ODT's 10-day average volume of 3,318,543 shares.

963,820

Display:

Providers:

UpdateCancel
6 providers

No news found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.